Maria Parham Health, formerly known as Maria Parham Hospital and the Maria Parham Medical Center, is a private, full-service regional hospital in Henderson, North Carolina that is part of Duke LifePoint. The historic 1925 building was listed on the National Register of Historic Places in 1994.

During the past decade, Maria Parham Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 13 clinical trials were completed, i.e. on average, 108.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maria Parham Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "Duke University" with 5 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "Daniel George, MD" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maria Parham Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Maria Parham Hospital" are "Breast Cancer" (4 trials), "Recurrent Breast Carcinoma" (4 trials), "Progesterone Receptor Positive" (3 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials) and "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Maria Parham Hospital" in a lesser frequency.

Most popular intervention types in "Maria Parham Hospital" are "Drug" (21 trials), "Other" (19 trials), "Biological" (6 trials), "Procedure" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Quality-of-Life Assessment" (5 trials), "Clinical Observation" (3 trials), "Paclitaxel" (3 trials) and "Placebo Administration" (3 trials). Other intervention names were less common.

The vast majority of trials in "Maria Parham Hospital" are 16 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Maria Parham Hospital". undefined are not yet recruiting, 3 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Maria Parham Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Maria Parham Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".